Display options
Cite
Jedlowski PM, Fazel M, Foshee JP, et al. A patient with concurrent prurigo nodularis and squamous cell carcinomas of keratoacanthoma type: The role of aprepitant in diagnostic clarity. JAAD Case Rep. 2019;6(1):3-5doi: 10.1016/j.jdcr.2019.10.014.
Jedlowski, P. M., Fazel, M., Foshee, J. P., & Curiel-Lewandrowski, C. (2020). A patient with concurrent prurigo nodularis and squamous cell carcinomas of keratoacanthoma type: The role of aprepitant in diagnostic clarity. JAAD case reports, 6(1), 3-5. https://doi.org/10.1016/j.jdcr.2019.10.014
Jedlowski, Patrick M, et al. "A patient with concurrent prurigo nodularis and squamous cell carcinomas of keratoacanthoma type: The role of aprepitant in diagnostic clarity." JAAD case reports vol. 6,1 (2020): 3-5. doi: https://doi.org/10.1016/j.jdcr.2019.10.014
Jedlowski PM, Fazel M, Foshee JP, Curiel-Lewandrowski C. A patient with concurrent prurigo nodularis and squamous cell carcinomas of keratoacanthoma type: The role of aprepitant in diagnostic clarity. JAAD Case Rep. 2019 Dec 24;6(1):3-5. doi: 10.1016/j.jdcr.2019.10.014. eCollection 2020 Jan. PMID: 31956685; PMCID: PMC6957794.
Copy Download .nbib Format: NLM
Share it on

JAAD Case Rep. 2019 Dec 24;6(1):3-5. doi: 10.1016/j.jdcr.2019.10.014. eCollection 2020 Jan.

A patient with concurrent prurigo nodularis and squamous cell carcinomas of keratoacanthoma type: The role of aprepitant in diagnostic clarity.

JAAD case reports

Patrick M Jedlowski, Mahdieh Fazel, James P Foshee, Clara Curiel-Lewandrowski

Affiliations

  1. University of Arizona College of Medicine, Tucson, Arizona.

PMID: 31956685 PMCID: PMC6957794 DOI: 10.1016/j.jdcr.2019.10.014

[No abstract available.]

Keywords: KA, keratoacanthoma; Mas-related g-protein receptors; Mrgprs, Mas-related G-protein-coupled receptors; NK1; NK1 antagonist; NK1, neurokinin 1; NMSC, non-melanoma skin caner; PN, prurigo nodularis; SCC, squamous cell carcinoma; aprepitant; chronic prurigo; chronic pruritus; human immunodeficiency disease; keratoacanthoma; neurokinin; neurokinin antagonist; non-melanoma skin cancer; prurigo; prurigo nodularis; pruritus; serlopitant; squamous cell carcinoma

References

  1. Biomed Res Int. 2017;2017:4790810 - PubMed
  2. Acta Derm Venereol. 2019 Apr 1;99(4):379-385 - PubMed
  3. Dermatol Clin. 2018 Jul;36(3):189-197 - PubMed
  4. PLoS One. 2010 Jun 04;5(6):e10968 - PubMed
  5. J Am Acad Dermatol. 2013 Sep;69(3):426-30 - PubMed
  6. J Allergy Clin Immunol. 2017 Aug;140(2):447-453.e3 - PubMed
  7. J Am Acad Dermatol. 2018 May;78(5):882-891.e10 - PubMed
  8. Saudi Med J. 2000 Mar;21(3):300-1 - PubMed
  9. JAMA Dermatol. 2019 Jan 1;155(1):118-120 - PubMed
  10. JCI Insight. 2016 Oct 06;1(16):e89362 - PubMed

Publication Types